InsidersTradesSigma
Explore the full record of transactions filed by KAY E GERALD, Chairman & CEO. Director active across 1 companies, notably Integrated Biopharma INC. Aggregated, 2 disclosures have been published. The latest transaction was disclosed on 6 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Gerald E. Kay is the Executive Chairman and President of Integrated Biopharma Inc. He leads the company's operations and strategy, providing a clear vision for its development. Kay has extensive experience in the biopharmaceutical sector, enabling him to guide the company towards innovation and sustainable growth.